Press Release: Spinifex : Spinifex Pharmaceuticals Pty Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

(PR-inside.com) Spinifex Pharmaceuticals Pty Ltd (Spinifex Pharma) is a biotechnology company that develops products for the treatment of pain. The company develops EMA401 for pain control. Its EMA401 is an AT2 receptor antagonist, which is used in the treatment of chronic pain. Spinifex Pharma conducts active medicinal chemistry program for discovery and development of selective AT2 receptor antagonists. The company's products are also used to treat post therapeutic neuralgia, painful diabetic neuropathy, neuropath pain associated with HIV infection, and inflammatory pain conditions, such as rheumatoid and osteoarthritis. It has presence in Australia and the US. Spinifex Pharma is headquartered in Preston, ..